Posted 26 September, 2022
CANNABIS SUISSE CORP. appointed new CEO
CEO Change detected for ticker OTC:CSUI in a 8-K filed on 26 September, 2022.
On the same date, Mr. Scott McAlister, the registrant's sole director, was appointed Chief Executive Officer and Chief Financial Officer.
Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of CANNABIS SUISSE CORP.
Basic Materials/Resources • Paper/Pulp
Cannabis Suisse Corp. engages in the business of producing over-the-counter products such as CBD oils, retail branded cigarettes, and some health-related supplements. It also offers flavored broad-spectrum CBD oils and CBD isolate tinctures with no THC. The company was founded on February 26, 2016 and is headquartered in Jacksonville, FL.Market Cap
$1.30M
View Company Details
$1.30M
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election Of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 25, 2022, Mr. John Carlin and Mr. Robert J. Carlin were terminated from their positions with the registrant as President with regard to Mr. John Carlin and Secretary/Treasurer (Principal Financial and Accounting Officer) with regard to Mr. Robert J. Carlin. On the same date, Mr. Scott McAlister, the registrant's sole director, was appointed Chief Executive Officer and Chief Financial Officer. Mr. McAlister, age 41, has been the owner of SWM Contractors, LLC, a commercial real estate development company since 2017. He has been in the commercial real estate development business for more than ten years. Mr. McAlister is a licensed general contractor in Florida. He graduated in 2005, from the University of North Florida, Jacksonville Florida. 2
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.